ABSTRACT
This work begins with the difference between sex and gender, then show that the contrasts in the field of health between men and women can be explained: by the construction of gender of consultants and health service providers, by the structure of the services themselves of health (which also reflects gender constructions), and by the reproduction of gender patterns through education and research. The work shows the need to include a gender perspective in health research.
Este trabajo inicia con la diferencia entre sexo y género, para mostrar que los contrastes en el campo de la salud entre hombres y mujeres pueden explicarse por la construcción de género de consultantes y de proveedores de servicios de salud, por la estructura de los propios servicios de salud (que refleja también construcciones de género) y por la reproducción de patrones de género a través de la educación y la investigación. El trabajo muestra la necesidad de incluir la perspectiva de género en la investigación en salud.
Subject(s)
Gender Identity , Sex Characteristics , Attitude of Health Personnel , Diabetes Mellitus, Type 2/epidemiology , Diabetes Mellitus, Type 2/genetics , Disease Susceptibility , Female , Genotype , Health Services , Healthcare Disparities , Humans , Male , Men/psychology , Phenotype , Professional-Patient Relations , Quality-Adjusted Life Years , Self Concept , Sex Distribution , Social Determinants of Health , Social Sciences , Socioeconomic Factors , Women/psychologyABSTRACT
OBJECTIVE: To discuss the diagnosis of spinal muscular atrophy in a child conceived using donor gametes. DESIGN: None. SETTING: None. PATIENT(S): Offspring of gamete donors. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): None. RESULT(S): A child conceived using gametes from anonymous sperm and ova donors was diagnosed with spinal muscular atrophy type 1. CONCLUSION(S): Gamete donor facilities are not required to perform extensive genetic testing on their donors; however, the well-being of the children conceived through assisted reproductive technologies should be a primary objective of reproductive medicine. The risk for specific medical problems in donor offspring can be significantly reduced by incorporating carrier screening for common, severe disorders such as spinal muscular atrophy into donor screening practices. Future efforts should focus on communicating the limitations of genetic screening to donor gamete recipients and educating them about their reproductive options.
